Incorporated in the U.S. in 2017, DeepTek is amongst very few medical imaging AI start-ups, which has successfully established commercial adoption of AI technology in clinical practice–creating clear and quantifiable value for patients, hospitals, and radiologists.
DeepTek’s vision is to provide cutting-edge solutions powered by deep learning algorithms that will bridge the wide gap in the imaging sector. DeepTek products have bagged multiple regulatory clearances including the coveted US FDA and CE Clearance. DeepTek is currently serving over 1000 hospitals across India, US, Singapore, Thailand, the Philippines, Nigeria, Kenya, and several other countries. In Singapore – DeepTek’s solution has been adopted as a National Radiology AI platform. DeepTek touches the lives of more than a million individuals every year.
DeepTek.ai has a team of 200+ members with a unique mix of technology experts and radiologists and is trusted by marquee equity partners like TATA Capital Healthcare Fund II and NTT DATA.